Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis

Table 2

Methylation/deletion frequencies in aggressive prostate cancer versus adenoma plus nonaggressive cancer.

Gene/locus	Methylation/deletion frequency, %		value
	Aggressive cancer	Adenoma and nonaggressive cancer
LOC440944/SETD5	100 (4/4)	10 (3/29)	<0.001
OSBPL10/ZNF860	100 (4/4)	7 (2/29)	<0.001
CLCN2	100 (4/4)	7 (2/29)	<0.001
PRSS42/MYL3	100 (4/4)	0 (0/29)	<0.001
VHL	75 (3/4)	0 (0/29)	<0.001
BBX	100 (4/4)	17 (5/29)	0.003
LMCD1	100 (4/4)	21 (6/29)	0.005
CMTM6	100 (4/4)	21 (6/29)	0.005
FAM19A4	100 (4/4)	21 (6/29)	0.005